Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
American Journal of Hematology
|
December 23, 2016
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials
Massimo Gentile, Valeria Magarotto, Massimo Offidani, et al.
Plos One
|
June 26, 2015
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques
Anna Grazia Recchia, Nadia Caruso, Sabrina Bossio, et al.
Leukemia Research
|
June 4, 2015
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment
Fortunato Morabito, Giovanna Cutrona, Laura Mosca, et al.
European Journal of Haematology
|
April 24, 2026
Regional Standardization of CLL Management: Results of a Delphi Consensus Process
Enrica Antonia Martino, Annalisa Chiarenza, Salvatrice Mancuso, et al.
Cancers
|
May 13, 2023
Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE)
Esther Natalie Oliva, Anna Candoni, Prassede Salutari, et al.
Non-Coding RNA
|
September 23, 2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study
Ennio Nano, Francesco Reggiani, Adriana Agnese Amaro, et al.
Frontiers in Oncology
|
August 19, 2021
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia
Fortunato Morabito, Giovanni Tripepi, Riccardo Moia, et al.
Annals of Hematology
|
March 28, 2021
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study
Salvatore Leotta, Uros Markovic, Maria Cristina Pirosa, et al.
International Journal of Molecular Sciences
|
November 9, 2024
Translational Research on Azacitidine Post-Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QOL-ONE Trans-2)
Esther Natalie Oliva, Maria Cuzzola, Matteo Della Porta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2013
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features
Fortunato Morabito, Laura Mosca, Giovanna Cutrona, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
American Journal of Hematology
|
December 23, 2016
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials
Massimo Gentile, Valeria Magarotto, Massimo Offidani, et al.
Plos One
|
June 26, 2015
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques
Anna Grazia Recchia, Nadia Caruso, Sabrina Bossio, et al.
Leukemia Research
|
June 4, 2015
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment
Fortunato Morabito, Giovanna Cutrona, Laura Mosca, et al.
European Journal of Haematology
|
April 24, 2026
Regional Standardization of CLL Management: Results of a Delphi Consensus Process
Enrica Antonia Martino, Annalisa Chiarenza, Salvatrice Mancuso, et al.
Cancers
|
May 13, 2023
Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE)
Esther Natalie Oliva, Anna Candoni, Prassede Salutari, et al.
Non-Coding RNA
|
September 23, 2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study
Ennio Nano, Francesco Reggiani, Adriana Agnese Amaro, et al.
Frontiers in Oncology
|
August 19, 2021
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia
Fortunato Morabito, Giovanni Tripepi, Riccardo Moia, et al.
Annals of Hematology
|
March 28, 2021
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study
Salvatore Leotta, Uros Markovic, Maria Cristina Pirosa, et al.
International Journal of Molecular Sciences
|
November 9, 2024
Translational Research on Azacitidine Post-Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QOL-ONE Trans-2)
Esther Natalie Oliva, Maria Cuzzola, Matteo Della Porta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2013
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features
Fortunato Morabito, Laura Mosca, Giovanna Cutrona, et al.
Page
of 12